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Abstract 
Background: Previous research has been able to establish an association between diabetes/ increased sugar levels 
and increased mortality, length of hospital stay, readmission rates, and poorer functional and rehabilitation outcomes 
after stroke. The present study was done to assess the link of the blood sugar levels with acute stroke and thereby 
evaluate the severity and prognosis of stroke with reference to hyperglycemia.Materials and method: The blood 
sugar and HbA1C levels at the time of admission were recorded. The severity of stroke for each patient is calculated 
based on NIH stroke scale, which takes the clinical findings in to account and each criteria awarded specific points. 
The Student's t-test was applied for the comparing the mean values, Chi-square test for the comparison of 
frequencies and Spearman’s correlation test for correlation between the 2 variables.Results: Maximum number of 
the subjects in the present study belonged to the age group of 51-60 years with predominance among the males. 
High sugar levels as assessed by Random blood sugar and HbA1C levels was associated with increased severity of 
stroke as per NIH stroke class severity and poor functional outcome as well as the mortality. 
Conclusion: There is a linear correlation between admission day hyperglycemia and the severity of ischemic stroke. 
There is a good correlation between glucose level at the time of admission and the ischemic stroke outcome.  
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Introduction 
 
Stroke is one of the major causes of disability and 
mortality all over the world.[1,2] Given its major 
socioeconomic burden, there is always a need to 
improve our understanding of its high risk population, 
complications, and prognosis.Diabetes is a major risk 
factor for stroke occurrence.[3] Hyperglycemia (blood 
glucose level >6.1mmol/L or 121 mg/dL) is common in 
early phase of stroke, even in patients without a 
previous diagnosis of diabetes mellitus. It has been 
found in two thirds of all stroke patients and in almost 
half of ischemic stroke patients.[4,5] 
_______________ 
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High glucose levels predict a larger infarct size, poor 
clinical outcome and a higher risk of mortality, and are 
independent from other predictors of a poor prognosis 
such as age, diabetic status and stroke severity.[6,7-12] 
Several mechanisms seem to account for the high 
frequency of hyperglycemia observed in patients with 
acute ischemic stroke, and various pathophysiological 
mechanisms have been proposed to account for the 
detrimental effect of hyperglycemia on the ischemic 
brain.A recent meta-analysis of prospective and case-
control studies confirmed the importance of early stress 
hyperglycemia as a predictor of stroke outcome, but 
debate continues as to whether the effect is independent 
of pre-existing diagnosis of diabetes or initial stroke 
severity. It is still not clear what cut-off value of the 
mean blood glucose level (MBGL) should be 
considered safe in diabetic and non-diabetic 
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patients.[13]Pulsinelli and colleagues found that 
neurological outcome was worse in patients with blood 
glucose levels > 120 mg/dl (6.7 mmol/l).[14] In a 
systematic review of hyperglycaemia and poststroke 
outcomes, Capes and colleagues included 32 studies 
and found that admission blood glucose > 108–144 
mg/dl (6–8 mmol/l) was associated with increased in-
hospital or 30-day mortality (relative risk of 3.1, in 
patients without diabetes compared to 1.3, in patients 
with diabetes).[15]Although hyperglycaemia is often 
attributed solely to the physiological stress of the acute 
stroke event, elevated blood glucose levels may reflect 
underlying glucose intolerance or diabetes mellitus. 
Approximately one-third of all patients with diabetes 
have undiagnosed diabetes (i.e. not recognized by their 
clinician).[16] Current guidelines recommend screening 
patients for diabetes if they have one or more risk 
factors for diabetes (e.g. age more than 45 years, 
hypertension, lipid abnormality, vascular disease, 
etc.).[17]The under-diagnosis of diabetes in the general 
population, together with the strong association of 
diabetes with stroke (stroke is often due to either micro- 
or macrovascular disease, and stroke patients often have 
other risk factors for diabetes),[18,19] suggests a 
rationale for screening all hyperglycaemic stroke 
patients for diabetes. A diagnosis of diabetes in a stroke 
patient would probably change the clinical management 
of that patient, specifically with respect to lipid and 
blood pressure management.[20,21]The present study 
was done to assess the link of the blood sugar levels 
with acute stroke and thereby evaluate the severity and 
prognosis of stroke with reference to hyperglycemia. 
Materials and method 
 
The study included 100 of acute ischemic stroke 
patients reporting to the ICU of Narayan Medical 
College & Hospital, Bihar between July 2019 to 
December 2019.  
Selection of study subjects 
The Patients were selected on the following basis 
Inclusion criteria: 
1. Patients should be above the age of forty 
2. Patients should have been admitted within twenty 
four hours of onset of symptoms 
3. This should be the first cerebro vascular accident 
for the patient 
4. Blood sugar recorded with in twenty four hours of 
the onset of stroke 
Exclusion criteria 
1. Patients admitted after twenty four hours of stroke 
2. Those patients who received intravenous glucose 
before or during study period 
3. Patients with reliable information about diabetes 
could not be obtained 
4. Patients who died before it could be established 
whether or not they had diabetes 
5. Illness presented with stroke like symptoms 
Study procedure 
Complete history was taken, clinical 
examination was done and clinical diagnosis for each 
patient was arrived. Blood pressure measurement, blood 
sugar, urea, creatinine, electrolytes, hemoglobin, total 
count, differential count; urine sugar, albumin, deposits; 
electrocardiogram and chest X ray done for all patients. 
The severity of stroke for each patient is calculated 
based on NIH stroke scale, which takes the clinical 
findings in to account and each criteria awarded specific 
points. The points were added, with a maximum of forty 
two points. 
 
Table  1:NHSS Score and stroke severity 
NIHSS Score Stroke severity 
0 No stroke symptoms 
1-4 Minor stroke 
5-15 Moderate stroke 
16-20 Moderate to severe stroke 
21-42 Severe stroke 
Once clinical diagnosis of acute stroke was made, the 
venous blood sample was taken, within 24 hours of 
onset of symptoms, and sent to laboratory for glucose 
estimation. In patients with blood sugar more than 6.1 
mmol/l (110 mg/dl)[22] and without a history of 
diabetes, Hemoglobin A1c was performed. 
(Hemoglobin A1C is structurally similar to hemoglobin 
A except for the addition of glucose. 
CT 
computerized tomography, CT, of the brain was 
performed in all patients to : Confirm the diagnosis 
Detect the type of stroke Detect the size of lesion (small 
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< 5mm; Medium 5 – 10 mm; Large > 10 mm or 
involving more than one vascular territory) Locate the 
site of lesion Identify the presence of cerebral edema or 
midline shift. 
 
Follow-up 
The patients were followed up for thirty days 
and outcome in the form of death; poor, moderate and 
good improvement was recorded. Patients who were 
unable to return to any form of work, persistent 
disability, need for residential placement, dependent in 
activities of daily life, and stable deficit with no 
recovery were classified as those with poor 
outcome.Patient whose symptoms improved, who were 
independent in attending day to day activities, 
improvement in motor function and aphasia and no 
persistent disability were grouped as patients with good 
outcome. Patients who fared in between these two 
groups were grouped as those with moderate outcome. 
 
Statistical analysis 
The data was entered into the Microsoft excel 
and analyzed using the SPSS version 25.0. The 
Student's t-test was applied for the comparing the mean 
values, Chi-square test for the comparison of 
frequencies and Spearman’s correlation test for 
correlation between the 2 variables. The p-value was 
considered to be at the significance level when it was 
below 0.05. 
 
Results 
There was a male preponderance in our study with 
62.0% males. Majority of the patients belonged to 51-
60 years age group (28.0%) followed by 61-70 years 
(26.0%), above 70 years (25.0%) and 40-50 years 
(21.0%). 
The distribution of the risk factors among the 
study population showed that 38.0% were hypertensive, 
74.0% had prior history of diabetes mellitus and 62.0% 
had abnormal lipid levels. History of smoking and 
alcohol was reported among 34.0% and 30.0% subjects 
respectively. (Table 2)At the time of the admission, 
normal random blood glucose levels were reported 
among 38.0% while the remaining 62.0% had elevated 
blood glucose levels. As per the HbA1C values, 
Diabetes was reported among 65.0% patients, with 
15.0% newly detected diabetics and 32.0% had stress 
hyperglycemia. (Table 2)The stroke severity was 
assessed with NIH Stroke scaling system. The patients 
with hyperglycemia had statistically significantly higher 
score in comparison to the Euglycemic patients as 
assessed by the random blood glucose levels and 
HbA1c levels. (Table 3, 4) 
Our study clearly shows a positive correlation (r 
= 0.71) between admission day sugar value and the 
outcome of stroke. Higher admission day elevated 
blood glucose level has increased mortality and high 
risk of poor functional recovery. (Table 5)At the end of 
thirty day follow-up, good functional recovery was 
reported among 75.0% patients with normal blood 
glucose levels. Whereas, 4.6%, 6.7% and 12.5% known 
diabetic, newly detected and stress hyperglycemics had 
good functional recovery. High mortality and poor 
functional outcome at the end of 30 day period of 
follow-up was reported among known diabetic, newly 
detected and stress hyperglycemics. (Table 6) 
 
Discussion 
Clinical outcome after stroke is highly variable 
and depends on many factors.[22] Accurate assessment 
of the expected outcome is important for clinical 
decision-making, to guide patient management and 
improve rehabilitation. It is also needed to plan 
discharge and to provide appropriate prognostic 
information to patients and his/her relatives.[23] 
The stroke patients in the current study were in 
the age range of 41-75 years of age with majority in the 
age range of 51-60 and 61-70 years which was quite 
similar to the study by Subhash et al, maximum patients 
were in the age group of 60–69 years (40%) in diabetic 
stroke and 60–69 (27.5%) in the non-diabetic group. 
Men were found to experience stroke more 
frequently in our study which was in similarity to the 
findings by Subhash et al, men were at a greater risk for 
stroke in both diabetic and non-diabetic group. Women 
often did not seek health care and believed in natural 
cure or native medicine. This possibly explains the 
significant decrease in the female gender. 
In line to our findings, Subhash et al reported 
that Diabetic stroke patients with a history of 
hypertension were 75% and that of non-diabetic group 
were 42.5%. Similar results were also found in the 
Copenhagen stroke study.[24] Hypertension is the 
single most important factor for all vascular diseases, in 
general, cardiac and cerebral, in particular, closely 
followed by DM. When both are present, risk is greater. 
DM hastens atherosclerosis, and atherosclerosis 
promotes hypertension. Therefore, the prevalence of 
stroke is higher in diabetics, hypertensives and 
metabolic syndrome. Diabetic stroke patients with a 
history of CAD were 32.5% and that of non-diabetic 
group were 27.5%. The observation in the present study 
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that previous history of CAD was more common in the 
DM than in the non-diabetics was similar to another 
study.[24 Coronary arteries as well as cerebral arteries 
are medium sized, and therefore, atherosclerotic 
changes contributory to the development of stroke also 
contribute to the higher incidence of stroke, more so, in 
diabetes.In our study, there was an increased severity of 
stroke as per the NIHSS classification with elevated 
blood sugar levels and HbA1C levels at the time of the 
admission which was similar to the study by 
Subramiam et al. Previous clinical trials have shown 
that hyperglycemia at admission is correlated with a 
worsened clinical outcome. In non-diabetic patients, 
stress hyperglycemia was associated with a 3-fold risk 
for fatal stroke at 30 days and a 1.4-fold risk for poor 
functional outcome as compared with normoglycemic 
patients.[15,25-27]In several thrombolysis trials, 
hyperglycemia has been found to be associated with 
decreased odds for neurological improvement and also 
with increased secondary haemorrhagic events, which 
leads to speculation that hyperglycemia might be 
partially responsible for the diminishing beneficial 
effect of rtPA and early reperfusion.[28,29] 
Subramanian et al demonstrated that ischemic patients, 
who had elevated admission day glucose level 
experienced a three and a half fold increased early 
mortality than euglycemics with similar results among 
non-diabetic patients. In the diabetic group since the 
sugar value before the onset of stroke was not known, 
the effect of stress in diabetic group could not be 
studied.Diabetes is typically associated with poorer 
functional outcome, especially in poorly controlled 
diabetes (HbA1c >7%). Diabetes has also been 
associated with worse neurological deterioration 
(decrease of National Institute of Health Stroke Scale 
points 1 at 3 months) and increased risk of hemorrhagic 
development in people treated with thrombolysis for 
ischemic stroke. An explanation for this might be 
incomplete recanalization after thrombolysis, as 
suggested in one study. Diabetes has been associated 
with a reduced amount of recovery after rehabilitation, 
higher risk of mortality in some but not all studies and a 
risk factor for recurrent ischemic stroke.[30]Similar to 
our study, Kes et al have shown that there is an 
unadjusted relative risk of in-hospital mortality within 
30 days of 0.68 among non-diabetic patients and of 0.39 
in diabetic patients. Non-diabetic patients with 
hyperglycemia had a 1.7 higher relative risk of in-
hospital 28-day mortality than diabetic patients, which 
correlates with previous studies showing a relative risk 
about 2.0 times higher in non-diabetic patients than 
diabetic patients.[15,25-27]Studies that compared three 
glycemic measures – FBG vs random admission 
glucose vs HbA1c – consistently found that elevated 
FBG (≥7 mmol/L),[31] random admission glucose or 
blood glucose 2-hour post OGTT (≥11.1 mmol/L)[32-
34] were independent predictors of poor neurological 
outcome,[32,34] higher rates of mortality[33,34] and 
stroke recurrence[34] post-stroke compared with a 
single HbA1c ≥6.5%. Receiver operating characteristic 
analysis[32] showed a different threshold of FBG in 
individuals with diabetes (FBG >7.8 mmol/L) compared 
with individuals without diabetes (FBG >6.05 mmol/L). 
In one study96, an elevated random glucose ≥11.1 
mmol/L was a poor prognostic marker in non-diabetics 
or individuals with diabetes with good control (HbA1c 
6.5% has also been found to be a predictor of 
symptomatic intracerebral hemorrhage after 
thrombolysis for ischemic stroke.[30]Several studies 
have confirmed that stress hyperglycemia is associated 
with a poor outcome [26,13,35]. Jorgensen and 
colleagues [26], in their large prospective Danish study 
found that plasma glucose level >11 mmol/L (>198 
mg/dL) was associated with hospital mortality of 17% 
for non-diabetic patients, 24% for those with known 
diabetes and 32% for patients with hyperglycemia with 
no history of previous diabetes. Capes and 
colleagues,[15] in their systematic review found that 
stress hyperglycemia upon hospital admission was 
associated with three folds higher risk of short-term 
mortality compared with patients with lower glucose 
levels. Possible theories which are considered to cause 
hyperglycaemia related brain damage include; acidosis, 
oxidative stress, reperfusion injury, interference with 
glucose/sodium transport and glucose related cortisol 
increase.[36]On a physiological and radiological level, 
stress hyperglycemia has been associated with a larger 
infarct volume on presentation,[37,38] and might 
contribute to poorer stroke recovery through impairment 
of the fibrinolytic process[39,40] and delayed 
reperfusion of the ischemic penumbra.[41] Relative 
insulin deficiency associated with increased lipolysis 
associated with hyperglycemia diminishes 
cerebrovascular reactivity. Even in nondiabetic patients 
stress hyperglycemia may be a marker of deficient 
glucose regulation in individuals with insulin resistance 
and developing diabetes mellitus.[42] By provoking 
anaerobic metabolism, lactic acidosis, calcium overload, 
decreased mitochondrial function and free radical 
production, hyperglycemia may be a cause of the direct 
membrane lipid peroxidation and cell lysis in the zone 
of the numbra and penumbra, leading to the direct death 
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of neurons and dysfunction of the blood-brain barrier 
and promoting hemorrhagic infarct conversion. Also, 
insulin resistance is a very well-known indirect risk 
factor for stroke onset due to increased thrombophilia, 
endothelial dysfunction and inflammation.[43] 
Table 2:showing the baseline characteristics of the study population 
  Number % 
Gender Male 62 62.0% 
Female 38 38.0% 
Age groups 40-50 years 21 21.0% 
51-60 years 28 28.0% 
61-70 years 26 26.0% 
Above 70 years 25 25.0% 
Risk factors Hypertension 68 68.0% 
Diabetes Mellitus 74 74.0% 
Dyslipidemia 62 62.0% 
Smoker 34 34.0% 
Alcoholic 30 30.0% 
Glycemic status (Based 
on HbA1c) 
Euglycemic 4 4.0% 
Known Diabetic 65 65.0% 
Newly Detected 15 15.0% 
Stress Hyperglycemics 16 16.0% 
Based on random 
blood glucose 
126-199 38 38.0% 
≥ 200 62 62.0% 
Fasting blood sugar 
level 
< 100 mg/dL (5.6 mmol/L) 35 35.0% 
≥ 126 mg/dL (7 mmol/L) 38 38.0% 
≥ 126 mg/dL (7 mmol/L) 27 27.0% 
 
Table 3: showing the association of HbA1c level with severity of Stroke (NIHSS class) 
 HbA1c level 
Stroke severity (NIHSS class) Euglycemic Known 
Diabetic 
Newly 
Detected 
Stress Hyperglycemics 
Minor 2 0 0 3 
50.0% 0.0% 0.0% 18.8% 
Moderate 2 25 9 13 
50.0% 38.5% 60.0% 81.3% 
Moderate to severe 0 20 1 0 
0.0% 30.8% 6.7% 0.0% 
Severe 0 20 5 0 
0.0% 30.8% 33.3% 0.0% 
Chi-square value = 8.908, p-value < 0.001*  
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Table 4: showing the association of Random blood sugar levels with severity of Stroke (NIHSS class) 
Stroke severity 
(NIHSS class) 
Random blood sugar level Fasting blood sugar level 
126-199 > 199 < 100 mg/dL 
(5.6 mmol/L) 
≥ 126 mg/dL 
(7 mmol/L) 
≥ 126 mg/dL 
(7 mmol/L) 
Minor 3 2 3 1 1 
7.9% 3.2% 8.6% 2.6% 3.7% 
Moderate 33 16 31 13 5 
86.8% 25.8% 88.6% 34.2% 18.5% 
Moderate to 
severe 
0 21 0 11 10 
0.0% 33.9% 0.0% 28.9% 37.0% 
Severe 2 23 1 13 11 
5.3% 37.1% 2.9% 34.2% 40.7% 
Chi-square value = 9.790, p-value < 0.001* Chi-square value = 8.148, p-value = 0.008* 
 
 
Table 5: Correlation of NIHSS score with HbA1c level and Random blood sugar level 
NIHSS score Pearson correlation coefficient 
(r) 
p-value 
HbA1C 0.801 < 0.001* 
Random blood sugar level 0.512 0.021* 
 
Table 6: showing the outcome among subjects with stroke 
 HbA1c level 
Recovery Euglycemic Known 
Diabetic 
Newly Detected Stress 
Hyperglycemics 
Death (within 30 days) 0 32 7 5 
0.0% 49.2% 46.7% 31.3% 
Poor functional outcome 1 30 7 9 
25.0% 46.2% 46.7% 56.3% 
Good functional recovery 
3 3 1 2 
75.0% 4.6% 6.7% 12.5% 
Chi-square value = 9.790, p-value < 0.001* 
 
 
Conclusion 
Diabetes is a highly prevalent comorbidity in 
acute stroke patients, and is associated with poorer 
stroke outcomes compared with people without 
diabetes. Acute hyperglycemia is strongly associated 
with poorer stroke outcomes in people with or without 
diabetes. The elevated glucose level at the time of 
admission was found to be a significant predictor of 
mortality and poor functional outcome after acute 
stroke.  
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